Replies to post #21 on Advanced Biotherapy (fka ADVB)

[drdata]

I have been a believer that this IP will generate a company for several years and have amassed a fairly large position. That said, I do not see any downside in executing on the Rights Offering. Does anyone see anything I am missing?

On the other hand why is it trading at 8 cents when 800M shares are being created at 1.5 cents?

Thanks in advance